Skip to main content
Journal of Applied Clinical Medical Physics logoLink to Journal of Applied Clinical Medical Physics
. 2014 Jan 6;15(1):279–289. doi: 10.1120/jacmp.v15i1.4600

Defining internal target volume using positron emission tomography for radiation therapy planning of moving lung tumors

Adam C Riegel 1,, M Kara Bucci 2, Osama R Mawlawi 3, Moiz Ahmad 4, Dershan Luo 5, Adam Chandler 3,6, Tinsu Pan 3,5
PMCID: PMC5711243  PMID: 24423860

Abstract

Substantial disagreement exists over appropriate PET segmentation techniques for non‐small cell lung cancer. Currently, no segmentation algorithm explicitly considers tumor motion in determining tumor borders. We developed an automatic PET segmentation model as a function of target volume, motion extent, and source‐to‐background ratio (the VMSBR model). The purpose of this work was to apply the VMSBR model and six other segmentation algorithms to a sample of lung tumors. PET and 4D CT were performed in the same imaging session for 23 patients (24 tumors) for radiation therapy planning. Internal target volumes (ITVs) were autosegmented on maximum intensity projection (MIP) of cine CT. ITVs were delineated on PET using the following methods: 15%, 35%, and 42% of maximum activity concentration, standardized uptake value (SUV) of 2.5 g/mL, 15% of mean activity concentration plus background, a linear function of mean SUV, and the VMSBR model. Predicted threshold values from each method were compared to measured optimal threshold values, and resulting volume magnitudes were compared to cine‐CT‐derived ITV Correlation between predicted and measured threshold values ranged from slopes of 0.29 for the simplest single‐threshold techniques to 0.90 for the VMSBR technique. R2 values ranged from 0.07 for the simplest single‐threshold techniques to 0.86 for the VMSBR technique. The VMSBR segmentation technique that included volume, motion, and source‐to‐background ratio, produced accurate ITVs in patients when compared with cine‐CT‐derived ITV.

PACS number: 87.57.nm

Keywords: PET/CT, treatment planning, tumor delineation, lung cancer

I. INTRODUCTION

The use of fluorodeoxyglucose positron emission tomography (FDG‐PET) in radiation therapy planning of lung cancer grew substantially after the hardware fusion of PET/CT scanners in the last decade facilitated the inherent coregistration of anatomical and functional imaging. The ability of PET/CT to image distant metastases can change treatment intent from curative to palliative, 1 , 2 , 3 , 4 and the use of PET/CT for target definition can significantly change gross tumor volumes (GTVs) by distinguishing between malignant tissue and atelectasis. 5 , 6 , 7 , 8

A noted advantage of PET/CT for target delineation is the reduction of interobserver variation. 2 , 4 , 5 , 9 If a target delineation method is not clearly defined, however, significant differences between observers may remain. 10 , 11 Automated segmentation techniques can decrease interobserver variation, and several methods based on phantom and/or patient imaging have been investigated, 6 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 Erdi et al. (16) found that 36%‐44% of maximum activity concentration (ACmax) correlated well with known sphere volumes in a stationary phantom and, in a later publication, the group settled on a single threshold of 42%. (6) Paulino and Johnstone (17) suggested a standardized uptake value (SUV) threshold of 2.5 g/mL, a value that originated from differentiation of benign versus malignant lesions in diagnostic PET imaging of non‐small cell lung cancer. (20) Nestle et al. (18) proposed thresholds at 15% of mean activity concentration (ACmean) plus background activity concentration to compare with CT‐defined GTV Black et al.13 developed a linear function of mean SUV using CT scans of different‐sized spheres.

Few studies actually consider motion in PET‐defined target volumes, despite the trend towards 4D imaging and increased margins to treat the “motion envelope” of the tumor. Acknowledging that moving objects are blurred in PET due to long acquisition times, Caldwell et al. (15) found that a threshold of 15% of ACmax can incorporate motion extent into the resulting contour. In a phantom study, Okubo et al. (19) found that 35% was the optimal threshold for large stationary or moving spheres.

We developed a segmentation method which incorporated tumor size, motion extent, and source‐to‐background ratio (SBR) in the determination of optimal activity concentration threshold. (21) Using an extensive series of phantom scans at varying sphere volume, sinusoidal motion extent, and SBR, multiple regression techniques were used to fit an analytical function called volume/motion/SBR or “VMSBR” model. This model described the threshold which best matched the motion envelope of the tumor as defined on cine CT.

The purpose of this study was to apply the VMSBR model and six other published segmentation methods to a group of lung tumors previously planned for radiation therapy. Ultimately, we hope to apply the VMSBR model to complex tumors where CT and PET can be used in a complementary fashion.

II. Materials and Methods

A. Imaging

Lung cancer patients who underwent 4D CT and PET/CT simulation in the same imaging session and demonstrated one or more solid lesions with relatively homogeneous uptake on PET without invasion into the chest wall or mediastinal regions were retrospectively included in the study under an IRB‐approved protocol. PET/CT and 4D CT simulations were performed on a Discovery ST 8‐slice PET/CT scanner (GEMS, Waukesha, WI). The 4D CT protocol used 120 kV, 100 mA, 0.5 s gantry rotation, 2 cm axial beam width, 2.5 mm slice thickness, 0.25 s cine interval, and cine duration equal to 1 average breathing cycle plus 1 s. For PET imaging, patients were injected with 477 to 740 MBq of 18FFDG and PET was acquired in 2‐D mode for 3 min per bed position from base of skull to midthigh. Attenuation correction was performed with respiratory‐averaged CT to ensure registered CT and PET data.(22) Images were reconstructed with OSEM iterative reconstruction utilizing 30 subsets and two iterations. Both PET and CT imaging used a 50 cm field of view with a 128×128 and 512×512 image matrix respectively. PET slice thickness was 3.27 mm and CT slice thickness was 2.5 mm. PET and 4D CT images were transferred to Pinnacle3 version 8.1w (Philips Medical Systems, Madison, WI) for contouring.

B. Target delineation on CT and PET

To form ITV on CT(ITVCT), gross tumor was contoured on the maximum intensity projection (MIP) generated from cine‐CT images. 23 , 24 Cine‐CT images are unsorted reconstructed CT images that are retrospectively sorted to form 4D CT phase imaging in General Electric CT scanners (GE Healthcare, Waukesha, WI). Since forming MIP from cine CT includes all images during a respiratory cycle (not a sampled subset), these MIPs can often more accurately capture full motion extent. (23) ITVs were generated using seed‐based 3D region growing autosegmentation, which was used to minimize observer variation and bias. A threshold of ‐425 HU was used to limit the region‐growing algorithm. 25 , 26 A radiation oncologist reviewed the cine‐generated MIP and 4D CT phase images and adjusted the ITVCT contours if necessary.

It should be noted that ITV in this work refers to the motion envelope of the tumor — that is, the voxels that contain tumor at some point during the respiratory cycle. This concept differs from the ICRU‐defined ITV, which includes a margin for microscopic extension and a population‐based expansion for motion. (27) Here, we explicitly determine the motion envelope of the tumor with cine CT.

ITVs were delineated on PET using six segmentation methods from the literature (collectively referred to as ITVPET, summarized in Table 1). ITV15%,ITV35%,ITV42%, and ITV2.5 were all single thresholds of ACmax or standardized uptake value (SUV). 6 , 15 , 16 , 17 , 19 ITV15%+BG was formed by calculating 15% of ACmean and adding the result to a background measurement. As described in Nestle et al., (18) ACmean was measured in pixels above 70% of ACmax and background was measured in a small region of interest (ROI) defined in the adjacent anatomical structure with the highest background activity. For ITVSUVmean, a starting threshold was required to measure SUVmean and was not explicitly stated. As per the authors’ suggestion, we chose an arbitrary threshold (70%ACmax) and iterated through the regression function five times. (13) All ITVs were formed using seed‐based, region‐growing automatic segmentation in Pinnacle3.

Table 1.

Tumor delineation methods

Delineation Technique Notation
15% of ACmax (15)
ITV15%
35% of ACmax (19)
ITV35%
42% of ACmax 6 , 16
ITV42%
SUV=2.5g/mL
(17)
ITV25
15% of ACmem+BG (18)
ITV15%+BG
0.307×SUVmean+0.588
(13)
ITVSUVmean
volume/motion/SBR (21)
ITVVMSBR
ACmax=maximum activity concentration; ACmean=mean activity concentration; SUV=standardized uptake value; BG=background; ITV=internal target volume.

C. New segmentation method of volume, motion, and SBR

The VMSBR model was developed by scanning a NEMA IEC phantom containing six spheres of varying diameter (10‐37 mm) at varying sinusoidal motion amplitudes (0‐30 mm) and varying SBR (0‐50) for a total of 252 combinations of these parameters. (21) Optimal thresholds as percent of ACmax were geometrically fit to the motion envelopes of the moving spheres by minimizing the surface separation between the two volumes. Results of these phantom analyses are shown in Fig. 1. An analytical function was fit to the optimal thresholds and the resulting function is shown in Eq. (1), where w is optimal threshold normalized to background, x is tumor volume in cubic centimeters, y is motion extent in millimeters, and z is SBR (which is unitless). The model was initially validated in our previous work using a phantom dataset acquired on a different PET/CT scanner with different reconstruction parameters (the same scanner and reconstruction parameters used in the current study) and three moving lung tumors. Surface agreement between PET and reference CT volumes was less than 2 mm. (21)

ln(w)=0.0634x13+0.1202y13+0.7327(ln(z))+0.0597(x13ln(z))0.1221(y13ln(z))0.0248(xy)130.9504 (1)

Figure 1.

Figure 1

Phantom‐derived optimal activity concentration thresholds versus motion, source to background, and volume (denoted by different symbols). Threshold values are normalized to background. These values were used to generate the analytical expression in Eq. (1).a

To determine input for Eq. (1), tumor volume and motion were determined by autosegmenting the end‐inspiration and end‐expiration phases of 4D CT. Volume was measured at end‐expiration, and motion was measured as the distance between the end‐inspiration and end‐expiration centroids. SBR of the PET image was determined by dividing tumor ACmean by background ACmean. ACmean in the tumor was determined by creating a ROI at 80% of ACmean and measuring the ACmean in the ROI. Background was measured by segmenting the ipsilateral lung, removing any areas of high uptake (e.g., tumors, inflammation, imperfect segmentation near the mediastinum), and measuring ACmean. (28) If a lesion was located close to the chest wall or mediastinum and the contour “bled” into these areas, ITVPET was manually trimmed based on structural boundary information from CT to eliminate spillover.

The measured SBR value was degraded by partial volume averaging (29) and tumor motion. (30) When Eq. (1) was derived from phantom scans, the nondegraded SBR value was used for regression. We therefore multiplied the degraded SBR in patient scans by a recovery coefficient (RC) derived from phantom scans to correct for size and motion degradation (Eq. (2)), where x is volume in cubic centimeters and y is motion in millimeters. (21)

RC=0.1991x1+0.0136y+0.0725x1y+0.8839 (2)

The recovered SBR value, tumor volume, and motion were plugged into Eq. (1) to generate the optimal threshold for each lesion. ITV produced using the VMSBR regression model (ITVVMSBR) was created by seed‐based, region‐growing autosegmentation of the PET image.

D. Analysis

Accuracy of the segmentation techniques was assessed two ways. First, the threshold value generated by each technique was compared to the optimal threshold value. The optimal threshold value was measured via the surface separation algorithm in a manner similar to our previous work on phantoms. (21) ROIs were segmented on PET images in 1% intervals of ACmax, converted to triangular mesh surfaces, and compared with ITVCT (Fig. 2). The volume producing the smallest surface separation was deemed “optimal”. Predicted threshold values from each segmentation technique were correlated with this measured optimal threshold. The second analysis compared ITVPET volume magnitudes with ITVCT using paired t‐tests method was used to determine the optimal activity concentration threshold which best matched ITVCT for each patient.

Figure 2.

Figure 2

Two simple spherical meshes are compared via the surface separation algorithm. From each sampling point on the “reference” mesh (in this case, the smaller sphere), the closest point on the other mesh surface is calculated. This

Correlations between measured optimal values and predicted values are shown in Fig. 5.a

III. RESULTS

Twenty‐four tumors (23 patients) fit our criteria, were registered, and were included in the analysis. ITV15% could not be segmented for six tumors because 15% of ACmax fell below the background activity concentration. Similarly, ITV2.5 could not be segmented for two tumors for the same reason. As such, t‐tests were performed with paired values, limiting the sample to 18 and 22 tumors respectively.

Figures 3 and 4 illustrate typical patient examples for all segmentation methods. ITVCT is denoted by the thick red line.

Figure 3.

Figure 3

PET/CT images of tumor 1 with internal target volume (ITV) contours: (a) transverse, (b) sagittal, and (c) coronal. ITVCT, shown in red, was delineated on the maximum intensity projection. Other ITVs were delineated on PET using methods described in Table 1. The VMSBR model (ITVVMSBR) is shown in green.

Figure 4.

Figure 4

PET/CT images of tumor 13 with internal target volume (ITV) contours: (a) transverse, (b) sagittal, and (c) coronal. ITVCT, shown in red, was delineated on the maximum intensity projection. Other ITVs were delineated on PET using methods described in Table 1. The VMSBR model (ITVVMSBR) is shown in green.

Volume, motion, “source”, and background measurements for the 24 tumors are shown in Table 2. Linear correlations (y=mx+b) of the measured thresholds and the predicted thresholds for each segmentation technique are shown in Fig. 5. The correlation of ITVVMSBR thresholds with measured values has a slope close to 1 (m=0.90), a y‐intercept closest to 0 (b=1.40), and the highest R2 value (R2=0.86).

Volume magnitude differences are summarized in Table 3. ITVSUVmean,ITV15%+BG, and ITVVMSBR all yielded nonsignificant differences with ITVCT, with the VMSBR technique yielding the lowest percent difference (5.15%). All single‐threshold techniques yielded volumes whose differences with ITVCT were statistically significant.

Table 2.

Volume, motion, tumor, and background characteristics of 24 lung tumors

Lesion Location Volume (cm3) Motion (mm) Tumor AC (Bq/mL) Background AC A (Bq/mL)
1 RLL 21.1 10.8 99801.6 3576.5
2 RUL 15.3 7.8 63799.8 2515.8
3 RLL 1.1 10.3 11910.4 3127.5
4 RLL 0.8 6.2 60414.2 2267.4
5 LUL 1.0 6.6 67181.7 5692.0
6 RUL 28.0 1.5 38936.3 2890.4
7 RLL 2.5 13.6 33286.9 2781.2
8 LUL 1.5 2.4 79330.4 3702.4
9 RUL 0.7 4.6 36930.2 3118.9
10 RML 0.6 2.2 27270.3 3110.9
11 RUL 13.6 1.0 121006 3043.0
12 LUL 1.1 8.0 10314.4 3202.8
13 LUL 10.3 8.6 46834.6 1953.3
14 LLL 0.4 8.8 12710.3 3078.1
15 RUL 3.6 4.0 20158.7 2750.5
16 LLL 2.2 15.0 18006.2 3510.5
17 LUL 4.8 3.1 21106.1 2330.7
18 RUL 2.7 2.7 42787.6 1809.4
19 RLL 0.7 1.5 38805.8 2488.2
20 RUL 1.6 6.3 65668.8 3080.7
21 LUL 1.5 2.7 41978.3 3384.9
22 LUL 5.2 0.6 65254.3 3680.7
23 LUL 0.1 1.0 8586.72 2409.0
24 LUL 0.5 5.1 42631.4 3683.0

AC=activity concentration; RUL=right upper lobe; RML=right middle lobe; RLL=right lower lobe; LUL=left upper lobe; LLL=left lower lobe.

Figure 5.

Figure 5

Correlation between predicted threshold values and measured optimal threshold values for each segmentation method. Best‐fit lines, their equations, and R2 values are shown in each plot.

Table 3.

Comparison of ITVPET with ITVCT for different segmentation methods

Notation
Volume±SEM(cm3)
p‐value
(ITVPETITVCT)±SEM
Percent Difference (%)
ITV15%
a
10.93±2.71
0.01 c
+1.05±0.89
±10.7%
ITV35%
4.15±0.99
<0.01
c
4.17±1.24
50.1%
ITV42%
3.12±3.93
<0.01
c
5.21±1.38
62.5%
ITV2.5
b
6.93±2.14
<0.01
c
1.99±0.73
22.3%
ITV2.5
6.36±1.67
0.14
1.96±0.60
23.6%
ITVSUVmean
7.02±1.67
0.33
1.30±0.65
15.7%
ITVVMSBR
7.89±1.76
0.39
0.43±0.55
5.15%
ITVCT
8.32±2.16
a

a N=18. Statistics calculated using paired values.

b

b N=22.

c

c Statistically significant differences.

SEM=standard error of the mean.

IV. DISCUSSION

Definition of target volumes using PET has been the topic of much research in recent years, but little agreement exists on how to use PET to define a target volume. 31 , 32 , 33 The current study compares seven contouring methods of varying complexity, including a new PET segmentation method developed using a series of phantom calibrations that incorporates tumor volume, motion, and SBR into a threshold‐producing analytical function.

The methodology utilized in the current study of comparing PET‐segmented volumes to CT‐segmented volumes is similar to several publications in the literature. 18 , 34 , 35 , 36 Hanna et al. (34) compared volumes from three single‐threshold and two SBR‐based PET segmentation techniques to 4D CT‐derived ITV and found that no segmentation algorithm adequately matched. Schaefer et al. (35) used regression methods to develop an SBR‐based approach and validated the technique on eight NSCLC patients by comparing PET volumes to CT volumes delineated by a radiation oncologist. The investigators found that percent volume difference ranged from ‐9% to +28%, averaging 6% larger in PET than CT. The authors attributed this positive skew to respiratory motion. Lamb et al. (36) used 4D PET to create “PET‐MIP” image sets and segmented PET ITVs at thresholds ranging from 20% to 40% of maximum SUV. The investigators compared these volumes to ITVs drawn by radiation oncologists on the 4D CT MIP and found good overlap between PET‐MIP volumes and CT‐MIP volumes.

The correlation of ITVVMSBR threshold and optimal threshold produced a slope close to 1(m=0.90), implying good correlation of predicted and optimal values, the y‐intercept closest to 0(b=1.40), implying little systematic over‐ or underestimation, and the highest R2 value (R2=0.86), implying the tightest spread of predicted values.

Previously, we found that SBR was the most influential variable in threshold prediction. (21) This result was consistent with Brambilla et al. (14) , who found that SBR was more influential than size for spheres over 10 mm in diameter. The fact that both ITV15%+BG and ITVSUVmean explicitly or implicitly account for SBR and both perform nearly as well as our technique suggests that considering SBR in segmentation is critical. Other authors have previously put forth this notion. 18 , 28 , 33 Our results indicate that considering motion, in addition to size and SBR, can further increase the accuracy of PET delineation when compared with 4D CT or cine CT.

The current manifestation of the VMSBR model represents a first approximation to many moving tumors and there are several ways the model can be improved. The measurement of SBR, and particularly the measurement of background, is evidently critical for segmentation and factors that affect SBR should be further investigated. Additionally, several assumptions were made in the development of the VMSBR model that should be explored further. First, the model was developed using one‐dimensional sinusoidal motion, which is obviously inaccurate for many lung tumors. 37 , 38 Second, the model was developed with spherical objects; tumors with spiculations or substantial asymmetry may not conform to the model. Third, we assumed that motion during 4D CT acquisition was essentially the same as motion during PET acquisition. Motion patterns, including amplitude, frequency, and baseline position, can change over time (39) , leading to mismatching volumes or misregistration. Fourth, the model was developed assuming homogeneous uptake, which is a reasonable assumption for smaller tumors, but not for larger tumors where heterogeneity, hypoxia, or necrosis occur. The impact of AC heterogeneity on the VMSBR model should be evaluated.

Nevertheless, the VMSBR model, along with other SBR‐inclusive algorithms, produced promising results. Single‐threshold techniques may be simpler, but Biehl et al. (12) suggest that single thresholds are inappropriate for target delineation and, given the results of this work, we must concur. Nestle et al. (18) found that 40% of ACmax underestimates CT volumes with a population‐based motion expansion. We had similar findings for both ITV42%(62.5%) and ITV35%(50.1%) when compared with a motion envelope explicitly determined on cine CT. Though access to 4D CT for motion measurement may be a limitation, considerable motion information can be extracted from image sets processed directly from cine CT. 23 , 24

The focus of the current study was segmentation of relatively homogeneous and spherical primary tumors where extent was easy to determine with CT. We wanted first to validate our model in simple clinical cases where PET and CT data are supplementary (they indicate the same volume), before applying the model to the larger lung cancer population where PET and CT are complementary (PET may indicate malignancies that are indiscernible on CT). (40) In future work, we will assess the efficacy of the VMSBR model in complex primary tumors and mediastinal lymph nodes (which can demonstrate significant motion 41 , 42 for delineation of locally advanced non‐small cell lung cancer.

V. CONCLUSIONS

A segmentation model for moving lung lesions in PET that incorporates tumor volume, motion, and SBR into determination of optimal activity concentration threshold was developed. The model, calibrated with an extensive series of phantom scans, was applied to 24 lung lesions to form ITVs. These ITVs, as well as six others generated using methods published in the literature, were compared with cine‐CT‐defined ITV. The VMSBR model produced ITVs that correlated well with ITVs generated from cine CT. Further research is required to examine portability of the model to different patient and scan conditions.

Supporting information

Supplementary Material

Conflict of Interest statement: A.G. Chandler is an employee of GE Healthcare. No conflicts of interest exist for any other authors of this manuscript.

REFERENCES

  • 1. Brink I, Schumacher T, Mix M, et al. Impact of [18F]FDG‐PET on the primary staging of small‐cell lung cancer. Eur J Nucl Med Mol Imaging. 2004;31(12):1614–20. [DOI] [PubMed] [Google Scholar]
  • 2. Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys. 2003;57(3):853–63. [DOI] [PubMed] [Google Scholar]
  • 3. Dizendorf EV, Baumert BG, von Schulthess GK, Lutolf UM, Steinert HC. Impact of whole‐body 18F‐FDG PET on staging and managing patients for radiation therapy. J Nucl Med. 2003;44(1):24–29. [PubMed] [Google Scholar]
  • 4. Mah K, Caldwell CB, Ung YC, et al. The impact of (18)FDG‐PET on target and critical organs in CT‐based treatment planning of patients with poorly defined non‐small‐cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys. 2002;52(2):339–50. [DOI] [PubMed] [Google Scholar]
  • 5. Ashamalla H, Rafla S, Parikh K, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys. 2005;63(4):1016–23. [DOI] [PubMed] [Google Scholar]
  • 6. Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non‐small cell lung cancer using positron emission tomography (PET). Radiother Oncol. 2002;62(1):51–60. [DOI] [PubMed] [Google Scholar]
  • 7. Nestle U, Walter K, Schmidt S, et al. 18F‐deoxyglucose positron emission tomography (FDG‐PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys. 1999;44(3):593–97. [DOI] [PubMed] [Google Scholar]
  • 8. van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG‐PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev. 2006;32(4):245–60. [DOI] [PubMed] [Google Scholar]
  • 9. Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non‐small‐cell lung tumors on CT: the impact of 18FDG‐hybrid PET fusion. Int J Radiat Oncol Biol Phys. 2001;51(4):923–31. [DOI] [PubMed] [Google Scholar]
  • 10. Berson AM, Stein NF, Riegel AC, et al. Variability of gross tumor volume delineation in head‐and‐neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol. Med Dosim. 2009;34(1):30–35. [DOI] [PubMed] [Google Scholar]
  • 11. Riegel AC, Berson AM, Destian S, et al. Variability of gross tumor volume delineation in head‐and‐neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys. 2006;65(3):726–32. [DOI] [PubMed] [Google Scholar]
  • 12. Biehl KJ, Kong FM, Dehdashti F, et al. 18F‐FDG PET definition of gross tumor volume for radiotherapy of non‐small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med. 2006;47(11):1808–12. [PubMed] [Google Scholar]
  • 13. Black QC, Grills IS, Kestin LL, et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys. 2004;60(4):1272–82. [DOI] [PubMed] [Google Scholar]
  • 14. Brambilla M, Matheoud R, Secco C, Loi G, Krengli M, Inglese E. Threshold segmentation for PET target volume delineation in radiation treatment planning: the role of target‐to‐background ratio and target size. Med Phys. 2008;35(4):1207–13. [DOI] [PubMed] [Google Scholar]
  • 15. Caldwell CB, Mah K, Skinner M, Danjoux CE. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys. 2003;55(5):1381–93. [DOI] [PubMed] [Google Scholar]
  • 16. Erdi YE, Mawlawi O, Larson SM, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer. 1997;80(12 Suppl):2505–09. [DOI] [PubMed] [Google Scholar]
  • 17. Paulino AC and Johnstone PA. FDG‐PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys. 2004;59(1):4–5. [DOI] [PubMed] [Google Scholar]
  • 18. Nestle U, Kremp S, Schaefer‐Schuler A, et al. Comparison of different methods for delineation of 18F‐FDG PET‐positive tissue for target volume definition in radiotherapy of patients with non‐Small cell lung cancer. J Nucl Med. 2005;46(8):1342–48. [PubMed] [Google Scholar]
  • 19. Okubo M, Nishimura Y, Nakamatsu K, et al. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system. Ann Nucl Med. 2008;22(7):579–86. [DOI] [PubMed] [Google Scholar]
  • 20. Patz EF, Jr. , Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F‐18 fluorodeoxyglucose PET scanning. Radiology. 1993;188(2):487–90. [DOI] [PubMed] [Google Scholar]
  • 21. Riegel AC, Bucci MK, Mawlawi OR, et al. Target definition of moving lung tumors in positron emission tomography: correlation of optimal activity concentration thresholds with object size, motion extent, and source‐to‐background ratio. Med Phys. 2010;37(4):1742–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Pan T, Mawlawi O, Nehmeh SA, et al. Attenuation correction of PET images with respiration‐averaged CT images in PET/CT. J Nucl Med. 2005;46(9):1481–87. [PubMed] [Google Scholar]
  • 23. Riegel AC, Chang JY, Vedam SS, Johnson V, Chi PC, Pan T. Cine computed tomography without respiratory surrogate in planning stereotactic radiotherapy for non‐small‐cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;73(2):433–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Pan T, Sun X, Luo D. Improvement of the cine‐CT based 4D‐CT imaging. Med Phys. 2007;34(11):4499–503. [DOI] [PubMed] [Google Scholar]
  • 25. Goo JM, Tongdee T, Tongdee R, Yeo K, Hildebolt CF, Bae KT. Volumetric measurement of synthetic lung nodules with multi‐detector row CT: effect of various image reconstruction parameters and segmentation thresholds on measurement accuracy. Radiology. 2005;235(3):850–56. [DOI] [PubMed] [Google Scholar]
  • 26. Kemerink GJ, Lamers RJ, Pellis BJ, Kruize HH, van Engelshoven JM. On segmentation of lung parenchyma in quantitative computed tomography of the lung. Med Phys. 1998;25(12):2432–39. [DOI] [PubMed] [Google Scholar]
  • 27. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report No. 50. Bethesda, Md.: ICRU; 1999. [Google Scholar]
  • 28. van Baardwijk A, Bosmans G, Boersma L, et al. PET‐CT‐based auto‐contouring in non‐small‐cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys. 2007;68(3):771–78. [DOI] [PubMed] [Google Scholar]
  • 29. Soret M, Bacharach SL, Buvat I. Partial‐volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932–45. [DOI] [PubMed] [Google Scholar]
  • 30. Boucher L, Rodrigue S, Lecomte R, Benard F. Respiratory gating for 3‐dimensional PET of the thorax: feasibility and initial results. J Nucl Med. 2004;45(2):214–19. [PubMed] [Google Scholar]
  • 31. Ford EC, Herman J, Yorke E, Wahl RL. 18F‐FDG PET/CT for image‐guided and intensity‐modulated radiotherapy. J Nucl Med. 2009; 50(10):1655–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Greco C, Rosenzweig K, Cascini GL, Tamburrini O. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non‐small cell lung cancer (NSCLC). Lung Cancer. 2007;57(2):125–34. [DOI] [PubMed] [Google Scholar]
  • 33. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]‐FDG‐PET and PET‐CT in the planning of radiotherapy for non‐small cell lung cancer (NSCLC): the technical basis, ICRU‐target volumes, problems, perspectives. Radiother Oncol. 2006;81(2):209–25. [DOI] [PubMed] [Google Scholar]
  • 34. Hanna GG, van Sornsen de Koste JR, Dahele MR, et al. Defining target volumes for stereotactic ablative radiotherapy of early‐stage lung tumours: a comparison of three‐dimensional 18F‐fluorodeoxyglucose positron emission tomography and four‐dimensional computed tomography. Clin Oncol R Coll Radiol. 2012;24(6): e71–80. [DOI] [PubMed] [Google Scholar]
  • 35. Schaefer A, Kremp S, Hellwig D, Rube C, Kirsch CM, Nestle U. A contrast‐oriented algorithm for FDG‐PET‐based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging. 2008;35(11):1989–99. [DOI] [PubMed] [Google Scholar]
  • 36. Lamb JM, Robinson C, Bradley J, et al. Generating lung tumor internal target volumes from 4D‐PET maximum intensity projections. Med Phys. 2011;38(10):5732–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Boldea V, Sharp GC, Jiang SB, Sarrut D. 4D‐CT lung motion estimation with deformable registration: quantification of motion nonlinearity and hysteresis. Med Phys. 2008;35(3):1008–18. [DOI] [PubMed] [Google Scholar]
  • 38. Mageras GS, Pevsner A, Yorke ED, et al. Measurement of lung tumor motion using respiration‐correlated CT. Int J Radiat Oncol Biol Phys. 2004;60(3):933–41. [DOI] [PubMed] [Google Scholar]
  • 39. Nehmeh SA, Erdi YE, Pan T, et al. Quantitation of respiratory motion during 4D‐PET/CT acquisition. Med Phys. 2004;31(6):1333–38. [DOI] [PubMed] [Google Scholar]
  • 40. Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG‐positron emission tomography in non‐small‐cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67(3):709–19. [DOI] [PubMed] [Google Scholar]
  • 41. Donnelly ED, Parikh PJ, Lu W, et al. Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four‐dimensional CT. Int J Radiat Oncol Biol Phys. 2007;69(2):580–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Bosmans G, van Baardwijk A, Dekker A, et al. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non‐small‐cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;71(1):139–44. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material


Articles from Journal of Applied Clinical Medical Physics are provided here courtesy of Wiley

RESOURCES